Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...
Blue Trust Inc. lowered its position in La-Z-Boy Incorporated (NYSE:LZB – Free Report) by 28.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and ...